202 related articles for article (PubMed ID: 7611175)
1. Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast.
Cook DL; Weaver DL
Am J Clin Pathol; 1995 Jul; 104(1):17-22. PubMed ID: 7611175
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
[TBL] [Abstract][Full Text] [Related]
3. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
Prasad AR; Divine G; Zarbo RJ
Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
[TBL] [Abstract][Full Text] [Related]
4. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.
Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM
Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified.
Cao AY; He M; Huang L; Shao ZM; Di GH
World J Surg Oncol; 2013 Apr; 11():91. PubMed ID: 23607710
[TBL] [Abstract][Full Text] [Related]
6. The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting.
Wong SW; Rangan AM; Bilous AM; Boyages J; Gebski V; Benson EM
Pathology; 1999 May; 31(2):90-4. PubMed ID: 10399161
[TBL] [Abstract][Full Text] [Related]
7. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
Pinto AE; André S; Pereira T; Silva G; Soares J
Pathobiology; 2006; 73(2):63-70. PubMed ID: 16943686
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
9. Practical breast carcinoma cell kinetics: review and update.
Meyer JS; McDivitt RW; Stone KR; Prey MU; Bauer WC
Breast Cancer Res Treat; 1984; 4(2):79-88. PubMed ID: 6378283
[TBL] [Abstract][Full Text] [Related]
10. [DNA ploidy is an independent prognostic biomarker in breast invasive ductal carcinoma].
Pinto AE; Pereira T; Silva GL; Ferreira MC; André S
Acta Med Port; 2012; 25(6):399-407. PubMed ID: 23534591
[TBL] [Abstract][Full Text] [Related]
11. S-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers.
Romero H; Schneider J; Burgos J; Bilbao J; Rodriguez-Escudero FJ
Breast Cancer Res Treat; 1996; 38(3):265-75. PubMed ID: 8739079
[TBL] [Abstract][Full Text] [Related]
12. Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.
Pinto AE; Pereira T; Silva GL; André S
Breast; 2015 Aug; 24(4):449-55. PubMed ID: 25920680
[TBL] [Abstract][Full Text] [Related]
13. DNA analysis and S-phase fraction determination by flow cytometric analysis of infiltrating lobular carcinoma of the breast.
Frost AR; Karcher DS; Terahata S; Siegel RS; Silverberg SG
Mod Pathol; 1996 Sep; 9(9):930-7. PubMed ID: 8878026
[TBL] [Abstract][Full Text] [Related]
14. Atypical medullary carcinoma of the breast has similar prognostic factors and survival to typical medullary breast carcinoma: 3,976 cases from the National Cancer Data Base.
Mateo AM; Pezzi TA; Sundermeyer M; Kelley CA; Klimberg VS; Pezzi CM
J Surg Oncol; 2016 Oct; 114(5):533-536. PubMed ID: 27393599
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.
Pedersen L; Larsen JK; Christensen IJ; Lykkesfeldt A; Holck S; Schiødt T
Breast Cancer Res Treat; 1994; 29(3):297-306. PubMed ID: 8049463
[TBL] [Abstract][Full Text] [Related]
16. [Expression of adhesive molecule CD44v6 and p53 gene in breast cancer tissues and its relation with DNA ploidy].
Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY
Ai Zheng; 2004 Nov; 23(11 Suppl):1418-22. PubMed ID: 15566648
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
18. DNA index and S-phase fraction and their combination as prognostic factors in operable ductal breast carcinoma.
Joensuu H; Toikkanen S; Klemi PJ
Cancer; 1990 Jul; 66(2):331-40. PubMed ID: 2164437
[TBL] [Abstract][Full Text] [Related]
19. Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer.
Pedersen L; Zedeler K; Holck S; Schiødt T; Mouridsen HT
Eur J Cancer; 1995 Dec; 31A(13-14):2289-95. PubMed ID: 8652258
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and cell proliferation in medullary carcinoma of the breast: a comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry.
Kajiwara M; Toyoshima S; Yao T; Tanaka M; Tsuneyoshi M
J Surg Oncol; 1999 Apr; 70(4):209-16. PubMed ID: 10219015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
